AtriCure, a leading manufacturer of equipment for treating atrial fibrillation, recently announced plans to create more than 100 jobs at its Mason, Ohio headquarters as part of a $15 million expansion.
To help facilitate the project, the city of Mason is selling Atricure five acres of land valued at $500,000. The city is also providing incentives valued at $3.6 million.
This includes a 15-year tax abatement valued at $2.8 million as well as a $500,000 loan. Workforce development and retention incentives were also included, and valued at $140,000. Additional training and hiring incentives are also being sought from the state of Ohio.
The project is expected to begin by April 1.
Average salaries of the new jobs are projected to be about $70,000. According to reports from city officials, 85% of Mason’s tax comes from businesses, which can be linked to these types of municipal investments. AtriCure employs more than 600 people globally and boasts the first and only device approved by the FDA for surgical treatment of persistent and longstanding persistent afib.